Literature DB >> 9925643

ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system.

L P Ford1, J Watson, J D Keene, J Wilusz.   

Abstract

We have developed an in vitro mRNA stability system using HeLa cell cytoplasmic S100 extracts and exogenous polyadenylated RNA substrates that reproduces regulated aspects of mRNA decay. The addition of cold poly(A) competitor RNA activated both a sequence-specific deadenylase activity in the extracts as well as a potent, ATP-dependent ribonucleolytic activity. The rates of both deadenylation and degradation were up-regulated by the presence of a variety of AU-rich elements in the body of substrate RNAs. Competition analyses demonstrated that trans-acting factors were required for RNA destabilization by AU-rich elements. The approximately 30-kD ELAV protein HuR specifically bound to RNAs containing an AU-rich element derived from the TNF-alpha mRNA in the in vitro system. Interaction of HuR with AU-rich elements, however, was not associated with RNA destabilization. Interestingly, recombinant ELAV proteins specifically stabilized deadenylated intermediates generated from the turnover of AU-rich element-containing substrate RNAs. These data suggest that mammalian ELAV proteins play a role in regulating mRNA stability by influencing the access of degradative enzymes to RNA substrates.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9925643      PMCID: PMC316394          DOI: 10.1101/gad.13.2.188

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  60 in total

Review 1.  Regulation of proto-oncogene mRNA stability.

Authors:  S C Schiavi; J G Belasco; M E Greenberg
Journal:  Biochim Biophys Acta       Date:  1992-12-16

2.  AUUUA motifs are dispensable for rapid degradation of the mouse c-myc RNA.

Authors:  A Bonnieu; P Roux; L Marty; P Jeanteur; M Piechaczyk
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

3.  An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3' untranslated region of lymphokine mRNA.

Authors:  P R Bohjanen; B Petryniak; C H June; C B Thompson; T Lindsten
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

4.  A uridylate tract mediates efficient heterogeneous nuclear ribonucleoprotein C protein-RNA cross-linking and functionally substitutes for the downstream element of the polyadenylation signal.

Authors:  J Wilusz; T Shenk
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

5.  A 32-kilodalton protein binds to AU-rich domains in the 3' untranslated regions of rapidly degraded mRNAs.

Authors:  E Vakalopoulou; J Schaack; T Shenk
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

6.  The c-fos transcript is targeted for rapid decay by two distinct mRNA degradation pathways.

Authors:  A B Shyu; M E Greenberg; J G Belasco
Journal:  Genes Dev       Date:  1989-01       Impact factor: 11.361

7.  A 3' truncation of MYC caused by chromosomal translocation in a human T-cell leukemia increases mRNA stability.

Authors:  D F Aghib; J M Bishop; S Ottolenghi; A Guerrasio; A Serra; G Saglio
Journal:  Oncogene       Date:  1990-05       Impact factor: 9.867

8.  The poly(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro.

Authors:  P Bernstein; S W Peltz; J Ross
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

9.  An A + U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro.

Authors:  G Brewer
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

10.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.

Authors:  D Caput; B Beutler; K Hartog; R Thayer; S Brown-Shimer; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

View more
  102 in total

1.  HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation.

Authors:  W Wang; M C Caldwell; S Lin; H Furneaux; M Gorospe
Journal:  EMBO J       Date:  2000-05-15       Impact factor: 11.598

2.  Identification of an erythroid-enriched endoribonuclease activity involved in specific mRNA cleavage.

Authors:  Z Wang; M Kiledjian
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

3.  HuR regulates p21 mRNA stabilization by UV light.

Authors:  W Wang; H Furneaux; H Cheng; M C Caldwell; D Hutter; Y Liu; N Holbrook; M Gorospe
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

Review 4.  Post-transcriptional regulation of tumour necrosis factor alpha production.

Authors:  P Anderson
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

5.  Interaction between a poly(A)-specific ribonuclease and the 5' cap influences mRNA deadenylation rates in vitro.

Authors:  M Gao; D T Fritz; L P Ford; J Wilusz
Journal:  Mol Cell       Date:  2000-03       Impact factor: 17.970

6.  The identification of an endonuclease that cleaves within an HuR binding site in mRNA.

Authors:  Z Zhao; F C Chang; H M Furneaux
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

7.  A U-rich element in the 5' untranslated region is necessary for the translation of p27 mRNA.

Authors:  S S Millard; A Vidal; M Markus; A Koff
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

Review 8.  Ribonucleoprotein infrastructure regulating the flow of genetic information between the genome and the proteome.

Authors:  J D Keene
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

9.  Loss of HuR is linked to reduced expression of proliferative genes during replicative senescence.

Authors:  W Wang; X Yang; V J Cristofalo; N J Holbrook; M Gorospe
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

10.  Posttranscriptional regulation of gene expression in learning by the neuronal ELAV-like mRNA-stabilizing proteins.

Authors:  A Quattrone; A Pascale; X Nogues; W Zhao; P Gusev; A Pacini; D L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.